1051. Characterization of Immune Responses to a Live-Attenuated Tetravalent Dengue Vaccine

BACKGROUND: A safe and effective vaccine against dengue is needed to address an unmet medical need that affects a large portion of the world’s population. Takeda’s live attenuated tetravalent dengue vaccine candidate (TAK-003) has shown protection in an ongoing Phase 3 efficacy trial. TAK-003 contai...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Ralph, Sharma, Mayuri, DeMaso, Christina, Parker, Allan, Dominguez, David, Watkins, Heather, Dean, Hansi, Karwal, Lovkesh, Nascimento, Eduardo, Messere, Nicole, Tsuji, Isamu, Zahralban-Steele, Melissa, Currier, Jeffrey R, Friberg-Robertson, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644738/
http://dx.doi.org/10.1093/ofid/ofab466.1245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644738/
http://dx.doi.org/10.1093/ofid/ofab466.1245

Ejemplares similares